Contract Pharmaceutical Manufacturing, Research and Packaging

Table of Contents

Contract Pharmaceutical Manufacturing, Research and Packaging

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY OBJECTIVES
• REASONS FOR DOING THIS STUDY
• INTENDED AUDIENCE
• SCOPE OF THE STUDY
• METHODOLOGY
• INFORMATION SOURCES
• ABOUT THE AUTHOR
• RELATED BCC RESEARCH REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY
• SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS)
• SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

• DEFINITIONS
• CONTRACT MANUFACTURING
• CONTRACT MANUFACTURER
• TYPES OF CONTRACT MANUFACTURERS
• CORE COMPETENCIES
• VENDOR
• CONTRACT RESEARCH ORGANIZATION (CRO)
• HISTORY OF OUTSOURCING
• HISTORY OF OUTSOURCING (CONTINUED)
• HISTORY OF OUTSOURCING (CONTINUED)

Chapter-4: CONTRACT MANUFACTURING

• NEED FOR CONTRACT MANUFACTURING
• FLEXIBILITY
• CAPACITY AND CAPITAL
• RISK
• ADVANTAGES OF CONTRACT MANUFACTURING
  • TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING
  • TABLE 1 (CONTINUED)
• SELECTION OF CONTRACT MANUFACTURER
• MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS

Chapter-5: CONTRACT RESEARCH

• INCLUDED IN RESEARCH
• DRUG DISCOVERY AND DEVELOPMENT
• CLINICAL RESEARCH
• ANALYTICAL RESEARCH
• NEED FOR CONTRACT RESEARCH
• SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION
• SELECTION AND MANAGEMENT OF CRO

Chapter-6: CONTRACT PACKAGING

• CONTRACT PACKAGING
• THE NEED FOR CONTRACT PACKAGING
• CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE
• LOCATION
• EXPERIENCE
• PERSONALITY
• FINANCIAL STRENGTH
• ADVANTAGES OF CONTRACT PACKAGING
• ADVANTAGES OF CONTRACT PACKAGING (CONTINUED)

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

• PROJECT EVALUATION AND SET UP
• PLANNING AND EXECUTION
• QUALITY MANAGEMENT
• MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT' S PERSPECTIVE
• MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE
• Management of Quality Components ... (Continued)

Chapter-8: REGULATORY ASPECTS

• SHORT SUPPLY ARRANGEMENTS
• DIVIDED MANUFACTURING ARRANGEMENTS
• SHARED MANUFACTURING ARRANGEMENTS
• RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER
• CONTRACT MANUFACTURING ARRANGEMENTS
• RESPONSIBILITIES OF LICENSED MANUFACTURER
  • TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS
• RESPONSIBILITIES OF THE CONTRACT MANUFACTURER
• WARNING LETTERS
• WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS
• Warning Letters Issued to ... (Continued)
• APPROVALS OF MANUFACTURING FACILITIES

Chapter-9: INDUSTRY STRUCTURE

• MARKET SHARES OF INDUSTRY LEADERS
• CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS
  • TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
  • FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
• CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
  • TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
  • TABLE 4 (CONTINUED)
  • FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
• CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
• NONSTERILE
  • TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
• STERILE
  • TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • TABLE 6 (CONTINUED)
  • FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
• CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
  • TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
  • FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
• CONTRACT RESEARCH COMPANIES
  • TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
  • FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
• CONTRACT PACKAGING COMPANIES
  • TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
  • FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
• TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
  • TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 10 (CONTINUED)
  • TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

Chapter-10: TECHNOLOGY TRANSFER

• REASONS FOR TECHNOLOGY TRANSFER
• CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
• PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER
• STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
• TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
• CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
• MATERIAL TRANSFER AGREEMENT (MTA)
• ASSIGNMENT DEED
• LICENSE AGREEMENT
• CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
• FACTORS FOR A SUCCESSFUL PROJECT
• FACTORS FOR A SUCCESSFUL PROJECT (CONTINUED)

Chapter-11: NEW DEVELOPMENTS

• QUINTILES INC.
• COVANCE
• CHARLES RIVER LABORATORIES
• OTHERS
• OTHERS (CONTINUED)
• OTHERS (CONTINUED)

Chapter-12: MARKETS

• CONTRACT MANUFACTURING
• CONTRACT MANUFACTURE OF BULK DRUGS/APIS
• Market Overview
• Market Overview (Continued)
• Market Revenue
  • TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
• Solid Dosage Formulations
• Market Overview
• Market Revenue
  • TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
• Market Revenue
  • TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS)
  • TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%)
• Liquid Dosage Formulations
• Market Overview
• Market Overview (Continued)
• Market Overview (Continued)
• Non-sterile Formulations
• Market Revenue
  • TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
  • FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Sterile Formulations
• Market Revenue
  • TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
• Non-sterile Formulations
  • TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
  • TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• Sterile Formulations
  • TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
  • TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
• Market Overview
• Market Overview (Continued)
• Market Revenue
  • TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• Market Shares
  • TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
  • TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
• CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
• Contract Manufacture ...(Continued)
• Market Overview
  • TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
  • TABLE 30 (CONTINUED)
• Market Revenue
  • TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%)
  • FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%)
• CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
• Market Overview
• Market Revenue
  • TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
• Market Shares
  • TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
• Market by Formulation
  • TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS)
  • FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS)
  • TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
  • FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
• CONTRACT RESEARCH
• MARKET OVERVIEW
• Partnerships
• Partnerships (Continued)
• Expansions of Facilities
• MARKET REVENUE
  • TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
• MARKET BY DISCIPLINE
  • TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS)
• MARKET SHARES BY DISCIPLINE
  • TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
  • FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
• CONTRACT PACKAGING
• MARKET OVERVIEW
• Market Overview (Continued)
• MARKET REVENUE
  • TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
  • FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
• MARKET BY PACKAGE TYPE
• MARKET REVENUE
  • TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS)
  • FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS)
• MARKET SHARES
  • TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)
  • FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

• CARDIOVASCULAR DRUG MARKET
• MARKET REVENUE
  • TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• REPRODUCTIVE DRUG MARKET
• MARKET REVENUE
  • TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ONCOLOGY DRUG MARKET
• MARKET REVENUE
  • TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANALGESIC MARKET
• MARKET REVENUE
  • TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANTIVIRAL DRUGS MARKET
• MARKET REVENUE
  • TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• ANTIBIOTICS MARKET
• MARKET REVENUE
  • TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
• MARKETS FOR OTHER DRUGS
• MARKET REVENUE
  • TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
  • FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Chapter-14: PATENT ANALYSIS

• PATENTS BY YEAR
  • TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009
  • FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009
  • FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005 - 2009 (%)
• PATENTS BY COMPANY
  • TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009
• PATENTS BY COUNTRY
  • TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009
  • TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%)
  • FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)
• PATENTS BY EMPHASIS
  • TABLE 58 PATENTS BY EMPHASIS, 2005-2009

Chapter-15: CURRENT ENVIRONMENT

• OVERALL SITUATION OF THE CONTRACTING MARKET
• CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
• CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
• CONTRACT RESEARCH
• CONTRACT PACKAGING
• SUCCESS FACTORS FOR CMOS
• PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET
• FROM THE PHARMACEUTICAL COMPANIES' PERSPECTIVE
• FROM CONTRACT MANUFACTURING ORGANIZATION' S PERSPECTIVE
• FACTORS AFFECTING THE OUTSOURCING MARKET
• COST CONTAINMENT
• GLOBALIZATION
• MERGERS AND ACQUISITIONS
• REGULATORY REQUIREMENTS
• NEED FOR SPECIALIZED SERVICES
• COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY
• INTRODUCTION OF NEW BIOTHERAPEUTICS

Chapter-16: COMPANY PROFILES

• AAI PHARMA, INC.
• ABBOTT LABORATORIES
• AEROGEN, INC.
• ALBANY MOLECULAR RESEARCH, INC.
• ALCAN PACKAGING
• ALKERMES, INC.
• AMERISOURCE BERGEN
• A. P. PHARMA, INC.
• ARADIGM CORPORATION
• BAXTER HEALTHCARE
• BEN VENUE LABORATORIES INC.
• BIOVAIL CORP.
• BOEHRINGER INGELHEIM
• BOOTS MANUFACTURING
• CAMBREX CORP.
• CANGENE
• CATALENT PHARMA SOLUTIONS
• CEDARBURG HAUSER PHARMACEUTICAL LTD.
• CENEXI
• CHARLES RIVER LABORATORIES
• CHEMBRIDGE CORP.
• CONFAB LABORATORIES
• COVANCE INC.
• DAVOS PHARMA
• DECODE GENETICS
• DIOSYNTH BIOTECHNOLOGY
• DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
• DOW CHEMICAL COMPANY
• DPT LABORATORIES INC.
• DR REDDY' S LABORATORIES
• DSM PHARMACEUTICAL PRODUCTS
• ELAN DRUG TECHNOLOGIES
• EVOTEC AG
• FULCRUM PHARMA PLC
• GENZYME PHARMACEUTICALS
• GIRINDUS AG
• GLAXOSMITHKLINE BIOPHARMACEUTICALS
• HOVIONE S.A.
• JUBILANT ORGANOSYS
• KENDLE INTERNATIONAL INC.
• KING PHARMACEUTICALS
• KP PHARMACEUTICAL TECHNOLOGIES INC
• K.V. PHARMACEUTICAL CO.
• LIGAND PHARMACEUTICALS
• LONZA GROUP
• LYNE LABORATORIES
• MALLINCKRODT
• MDS PHARMA SERVICES
• MEDAREX INC.
• MIKART INC
• NORWICH PHARMACEUTICALS
• NOVAVAX, INC.
• OMNICARE CLINICAL RESEARCH
• PAREXEL INTERNATIONAL CORPORATION
• PATHEON INC.
• PERRIGO COMPANY
• PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
• PIRAMAL HEALTHCARE
• PRA INTERNATIONAL
• QUINTILES
• RANBAXY RESEARCH LABS
• REGIS TECHNOLOGIES, INC.
• SCHWARZ PHARMA AG
• SKYEPHARMA
• TALECRIS BIOTHERAPEUTICS INC.
• WUXI APP TEC
• XCELLEREX, LLC
• APPENDIX : ABBREVIATIONS
• APPENDIX
• APPENDIX (CONTINUED)